Why the study?
Does Prothrombin Complex Concentrate (PCC) at 25 IU/kg improve achieving a target INR of 1.5 in patients with severe bleeding related to Vitamin K Antagonist (VKA)?
Does Prothrombin Complex Concentrate (PCC) at 25 IU/kg improve achieving a target INR of 1.5 in patients with severe bleeding related to Vitamin K Antagonist (VKA)?
A dose of 25 IU/kg of Prothrombin Complex Concentrate appears efficacious for achieving a target INR of 1.5 in patients with severe VKA-related bleeding.
Answers are grounded in this paper and cite their sources.
May support 25 IU/kg PCC for VKA reversal; leaves open need for randomized confirmation.
Severe bleeding related to VKA needs to be better managed, particularly regarding the PCC infused dose, INR monitoring and administration of vitamin K. A dose of 25 IU/kg PCC appears to be efficacious in achieving a target INR of 1.5. Further studies are required to assess whether adjusting PCC dose and/or better management of INR would improve outcomes.
No takes yet. Share an insight, caveat, or question.
Desmettre et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: